Related Experiment Videos
Chitosan-alginate microparticles as a protein carrier
G Coppi1, V Iannuccelli, E Leo
1Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy. coppi.gilberto@unimo.it
Drug Development and Industrial Pharmacy
|July 13, 2001
Summary
This study developed stable alginate-based microsystems for oral peptide drug delivery. Optimized cross-linking conditions enhanced protein loading, showing promise for improved drug absorption.
Area of Science:
- Biomaterials Science
- Pharmaceutical Technology
- Drug Delivery Systems
Background:
- Oral administration of peptide drugs is challenging due to gastric degradation and poor absorption.
- Developing effective carriers is crucial for enhancing the bioavailability of peptide therapeutics.
Purpose of the Study:
- To develop and characterize alginate-based microsystems for oral delivery of peptide drugs.
- To investigate the effect of cross-linking conditions on protein loading and stability.
- To evaluate the potential of these microsystems for targeting intestinal absorption sites.
Main Methods:
- Utilized spray-drying to create bovine serum albumin (BSA)-loaded alginate microparticles.
- Employed calcium chloride and chitosan (CS) for microparticle hardening and stabilization.
- Investigated the impact of CS concentration and pH on BSA loading and microsystem properties.
- Performed rheological measurements to confirm BSA-alginate interactions.
Main Results:
- Successfully produced sub-10-micrometer spherical alginate microspheres.
- Optimized cross-linking with chitosan significantly enhanced BSA loading, particularly at pH below the protein's isoelectric point (pI).
- Confirmed the formation of a BSA/alginate complex contributing to higher loading efficiency.
- Demonstrated the potential for microsystems to target Peyer's patches.
Conclusions:
- Alginate-based microsystems offer a promising strategy for oral peptide drug delivery.
- Controlled cross-linking is key to maximizing protein encapsulation and stability.
- The developed microcarriers show potential for improving oral bioavailability of peptide drugs.